An Act relative to capping the price of epinephrine

This bill (HD 2903) requires health insurance plans to cover epinephrine autoinjectors for anaphylaxis treatment with specific cost limits. It mandates that coverage for one brand-name or generic epinephrine autoinjector (sold as a two-pack) cannot include deductibles or co-insurance, and co-payments must not exceed $60. The law directly affects individuals with severe allergies requiring emergency epinephrine treatment, ensuring predictable out-of-pocket costs for this critical medication. It amends multiple sections of health insurance law to explicitly include anaphylaxis as a covered condition and set the $60 co-pay cap.